Countouriotis Athena Insider Trading
Get the latest insider transactions of Countouriotis Athena. Countouriotis Athena is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG). Discover the current value of Countouriotis Athena shares.
Address: C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO 92121CA
Countouriotis Athena is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| AMBI | AMBIT BIOSCIENCES CORP | Chief Medical Officer | 0 | 0.00 |
| GYHT | HALOZYME THERAPEUTICS, INC. | SVP and Chief Medical Officer | 45,977 | 0.00 |
| ADVM | Adverum Biotechnologies, Inc. | SVP, Chief Medical Officer | 150,000 | 0.00 |
| XNOM.OB | Cardiff Oncology, Inc. | Director | 0 | 0.00 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Director | 0 | 0.00 |
| TPTX | Turning Point Therapeutics, Inc. | President & CEO | 68,195 | |
| PASG | Passage BIO, Inc. | Director | 18,900 |
Insider Trading Transactions of Countouriotis Athena
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 3.20 | 18,000 | 57,600 | 68,195 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 3.20 | 7,666 | 24,531 | 75,861 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 136.29 | 6,200 | 844,998 | 69,661 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 137.58 | 103 | 14,171 | 69,558 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 138.66 | 4,969 | 689,002 | 64,589 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 139.69 | 13,290 | 1,856,480 | 51,299 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 140.24 | 1,104 | 154,825 | 50,195 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 3.20 | 25,392 | 81,254 | 75,587 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 134.34 | 1,025 | 137,699 | 74,562 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 135.72 | 5,227 | 709,408 | 69,335 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 136.42 | 16,626 | 2,268,119 | 52,709 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 137.46 | 2,081 | 286,054 | 50,628 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 138.19 | 433 | 59,836 | 50,195 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 3.20 | 8,942 | 28,614 | 59,137 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 136.45 | 4,319 | 589,328 | 54,818 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 137.66 | 1,571 | 216,264 | 53,247 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Sell | 138.55 | 3,052 | 422,855 | 50,195 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Option Exercise | 3.20 | 18,000 | 57,600 | 207,723 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Option Exercise | 3.20 | 7,666 | 24,531 | 67,575 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Option Exercise | 3.20 | 25,392 | 81,254 | 182,331 |
| Feb 11 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Option Exercise | 3.20 | 8,942 | 28,614 | 173,389 |
| Feb 10 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 0.00 | 22,617 | 0 | 50,195 |
| Feb 10 2021 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Option Exercise | 140.01 | 101,775 | 14,249,518 | 101,775 |
| Jun 10 2020 | IOVA | IOVANCE BIOTHERAPEUTICS, ... | Countouriotis Athena | Director | Option Exercise | 32.17 | 35,000 | 1,125,950 | 35,000 |
| May 26 2020 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 60.00 | 4,166 | 249,960 | 26,872 |
| Mar 25 2020 | PASG | Passage BIO, Inc. | Countouriotis Athena | Director | Buy | 14.98 | 10,000 | 149,750 | 18,900 |
| Mar 25 2020 | PASG | Passage BIO, Inc. | Countouriotis Athena | Director | Buy | 14.98 | 10,000 | 149,750 | 18,900 |
| Mar 02 2020 | PASG | Passage BIO, Inc. | Countouriotis Athena | Director | Option Exercise | 18.00 | 33,836 | 609,048 | 33,836 |
| Jan 08 2020 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 31.13 | 706 | 21,976 | 22,706 |
| Jan 08 2020 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Option Exercise | 63.33 | 325,000 | 20,582,250 | 325,000 |
| Sep 11 2019 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 45.00 | 10,000 | 450,000 | 22,000 |
| Jun 24 2019 | XNOM.OB | Trovagene, Inc. | Countouriotis Athena | Director | Option Exercise | 2.48 | 44,734 | 110,940 | 46,019 |
| Jun 11 2019 | IOVA | IOVANCE BIOTHERAPEUTICS, ... | Countouriotis Athena | Director | Option Exercise | 19.93 | 35,000 | 697,550 | 35,000 |
| Apr 24 2019 | TPTX | Turning Point Therapeutic ... | Countouriotis Athena | President & CEO | Buy | 18.00 | 12,000 | 216,000 | 12,000 |
| Feb 20 2018 | ADVM | Adverum Biotechnologies, ... | Countouriotis Athena | SVP, Chief Medical Of ... | Option Exercise | 6.40 | 160,000 | 1,024,000 | 160,000 |
| Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Countouriotis Athena | Director | Option Exercise | 0.30 | 54,322 | 16,297 | 92,428 |
| Jun 21 2017 | ADVM | Adverum Biotechnologies, ... | Countouriotis Athena | SVP, Chief Medical Of ... | Buy | 0.00 | 150,000 | 0 | 150,000 |
| Jun 21 2017 | ADVM | Adverum Biotechnologies, ... | Countouriotis Athena | SVP, Chief Medical Of ... | Option Exercise | 2.90 | 213,000 | 617,700 | 213,000 |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Buy | 0.00 | 18,496 | 0 | 45,977 |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Sell | 12.26 | 6,900 | 84,594 | 39,077 |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 0.00 | 18,496 | 0 | 55,487 |
| Jan 09 2017 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Buy | 0.00 | 7,500 | 0 | 27,481 |
| Jan 09 2017 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 0.00 | 7,500 | 0 | 15,000 |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Buy | 0.00 | 6,450 | 0 | 20,088 |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Sell | 8.63 | 107 | 923 | 19,981 |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 0.00 | 6,450 | 0 | 6,450 |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 0.00 | 6,450 | 0 | 0 |
| Feb 04 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 8.11 | 125,523 | 1,017,992 | 125,523 |
| Feb 04 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 0.00 | 73,983 | 0 | 73,983 |
| Jan 07 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Buy | 0.00 | 7,500 | 0 | 16,895 |
| Jan 07 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Sell | 16.39 | 3,257 | 53,382 | 13,638 |
| Jan 07 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Option Exercise | 0.00 | 7,500 | 0 | 22,500 |
| Jan 04 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Buy | 0.00 | 15,050 | 0 | 15,050 |
| Jan 04 2016 | GYHT | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical ... | Sell | 17.33 | 5,655 | 98,001 | 9,395 |
| Nov 12 2014 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 6.00 | 100,645 | 603,870 | 0 |
| Nov 12 2014 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 11.81 | 76,481 | 903,241 | 0 |
| Nov 12 2014 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 10.80 | 45,000 | 486,000 | 0 |
| Nov 12 2014 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 0.00 | 18,882 | 0 | 0 |
| May 19 2014 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 0.00 | 18,882 | 0 | 18,882 |
| Jan 10 2014 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 10.80 | 45,000 | 486,000 | 45,000 |
| Jul 18 2013 | AMBI | AMBIT BIOSCIENCES CORP | Countouriotis Athena | Chief Medical Officer | Option Exercise | 11.81 | 76,481 | 903,241 | 76,481 |